Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2158051 (At-406, AT-406, D-1143, Debio 1143, DEBIO-1143, IAP INHIBITOR AT-406, MSC2735845A, SM-406, Xevinapant) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
baculoviral IAP repeat containing 2/Baculoviral IAP repeat-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5462] [GtoPdb: 2791] [UniProtKB: Q13490] | ||||||||
GtoPdb | Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli. | - | 8.72 | pKi | 1.9 | nM | Ki | J Med Chem (2011) 54: 2714-26 [PMID:21443232] |
ChEMBL | Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 8.72 | pKi | 1.9 | nM | Ki | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
ChEMBL | Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 7.46 | pIC50 | 35 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 7.47 | pIC50 | 34 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Competitive inhibition of human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 7.91 | pIC50 | 12.3 | nM | IC50 | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
baculoviral IAP repeat containing 3/Baculoviral IAP repeat-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5335] [GtoPdb: 2792] [UniProtKB: Q13489] | ||||||||
GtoPdb | Competitive inhibition of human cIAP2 BIR3 domain expressed in Escherichia coli. | - | 8.29 | pKi | 5.1 | nM | Ki | J Med Chem (2011) 54: 2714-26 [PMID:21443232] |
ChEMBL | Competitive inhibition of human cIAP2 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 8.29 | pKi | 5.1 | nM | Ki | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
ChEMBL | Inhibition of N-terminal 6x-His-tagged recombinant human cIAP2-BIR3 (244 to 349 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 6.88 | pIC50 | 133 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Inhibition of N-terminal 6x-His-tagged recombinant human cIAP2-BIR3 (244 to 349 residues) expressed in Escherichia coli incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 7.36 | pIC50 | 44 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Competitive inhibition of human cIAP2 BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 7.66 | pIC50 | 22.1 | nM | IC50 | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
Genome polyprotein in Zika virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523954] [UniProtKB: A0A024AXB9] | ||||||||
ChEMBL | Binding affinity to N-terminal His-tagged Zika virus NS2B-NS3 protease (1 to 187 residues) using Boc-Gly-Arg-Arg-AMC as substrate | B | 5.05 | pKd | 9000 | nM | Kd | Bioorg Med Chem Lett (2020) 30: 126965-126965 [PMID:31980339] |
ChEMBL | Inhibition of N-terminal His-tagged Zika virus NS2B-NS3 protease (1 to 187 residues) using Boc-Gly-Arg-Arg-AMC as substrate | B | 4.87 | pKi | 13500 | nM | Ki | Bioorg Med Chem Lett (2020) 30: 126965-126965 [PMID:31980339] |
ChEMBL | Inhibition of N-terminal His-tagged Zika virus NS2B-NS3 protease (1 to 187 residues) using Boc-Gly-Arg-Arg-AMC as substrate | B | 5.39 | pIC50 | 4100 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 126965-126965 [PMID:31980339] |
X-linked inhibitor of apoptosis/Inhibitor of apoptosis protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4198] [GtoPdb: 2790] [UniProtKB: P98170] | ||||||||
ChEMBL | Competitive inhibition of human XIAP BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 7.18 | pKi | 66.4 | nM | Ki | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
GtoPdb | Competitive inhibition of human XIAP BIR3 domain expressed in Escherichia coli. | - | 7.18 | pKi | 66.4 | nM | Ki | J Med Chem (2011) 54: 2714-26 [PMID:21443232] |
ChEMBL | Competitive inhibition of human XIAP BIR3 domain expressed in Escherichia coli BL21(DE3) after 2 to 3 hrs by fluorescence polarization assay | B | 6.65 | pIC50 | 225 | nM | IC50 | J Med Chem (2011) 54: 2714-2726 [PMID:21443232] |
ChEMBL | Inhibition of N-terminal His-tagged human XIAP-BIR3 (253 to 347 residues) expressed in Escherichia coli BL21-Gold(DE3) pLysS incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 7.32 | pIC50 | 47.8 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Inhibition of N-terminal His-tagged human XIAP-BIR3 (253 to 347 residues) expressed in Escherichia coli BL21-Gold(DE3) pLysS incubated for 2 hrs without 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA | B | 7.38 | pIC50 | 42 | nM | IC50 | J Med Chem (2019) 62: 9188-9200 [PMID:31550155] |
ChEMBL | Antagonist activity at full-length FLAG-tagged XIAP (unknown origin) transfected in HEK293 cells assessed as inhibition of interaction with caspase 9 after 2 hrs by immunoprecipitation assay | B | 7.47 | pEC50 | 34 | nM | EC50 | J Med Chem (2015) 58: 6574-6588 [PMID:26218264] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]